Reading IBM? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track IBM free→Reading IBM? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track IBM free→
NYSEInformation TechnologyInformation Technology ServicesSnapshot 2026-06-12
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
Recent financial performance is neutral. Earnings quality is also neutral. Management's recent track record has been fairly steady. Risk is moderate, and the sector backdrop is a tailwind. Compared with sector peers, IBM is typical. Peer multiples imply a price about 123% below where it trades (it looks expensive on this basis); the read is rich. This is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 6 valuation methods, at three horizons. Current price $272.24. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $272 the market pays 23× p/e — above the 10× p/e peer median but in line with its own 19× history. That premium reflects a durable franchise our peer-anchored $118 fair value understates; treat the 'expensive vs peers' read with low confidence. Analysts: $215–$350. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The market is pricing in roughly 131% near-term growth, well above our forecast of about 9%. This describes what's priced in, not a forecast of the move.
Flags: expensive valuation, weak execution quality, a turbulent sector regime (Heating).
For similar setups historically (n=889): about 49% saw a 20%+ drawdown, and roughly 85% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Information Technology names rated neutral grew net income 54% of the time over the next year (vs 68% for the rest of the cohort, n=3704).
Over the trailing year it converted 1.30x of net income into operating cash flow. Historically, Information Technology names rated neutral grew net income 62% of the time over the next year (vs 58% for the rest of the cohort, n=2831).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $3.03 → $3.02 (-0.5% / 30d). 2 raised, 0 cut, 19 covering analysts.
0 upgrades, 0 downgrades / 30d, 2 maintained. 57% of analysts rate Buy.
3 PT revisions / 30d. Avg target 13.8% above current price.
0 positive, 0 negative / 30d.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$156.
How much price usually moves either way.
On a bad day, this stock has moved -$324.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $3,146.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
No material changes since the prior snapshot.
as of 2026-06-12
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Earnings results will provide insight into revenue growth and cash flow performance.
Confirms one read:Earnings report shows strong revenue growth and cash flow.
Confirms the other:Earnings report indicates weak revenue growth and cash flow.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
Advances: Invest over $10B in quantum over 5 years
Significant investment aligns with quantum growth strategy.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
is being furnished with the Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, and includes the following information to be provided by senior management at investor meetings on May 28, 2026: • Over the next 5 years IBM plans to invest more than $10B to advance our leadership position in quantum, including in R&D, capex, ecosystem partnerships, manufacturing scaling, and M&A, which further enhances our confidence in delivering the fir…
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
$215.00 – $350.00 (median $320.00) · 11 analysts · as of 2026-06-02
Looks more expensive than peers.
Richer than its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
A side-by-side read on sector standing, valuation, and risk versus IT Consulting & Other Services.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
IBM IBM | Typical Show detailsSector percentile: 32 of 100 | expensive | moderate |
ACN Accenture | Above typical Show detailsSector percentile: 98 of 100 | full | elevated |
CTSH Cognizant | Above typical Show detailsSector percentile: 90 of 100 | fair | elevated |
APLD APPLIED DIGITAL CORPORATION | Below typical Show detailsSector percentile: 19 of 100 | expensive | high |
IT Gartner | Above typical Show detailsSector percentile: 88 of 100 | full | elevated |
2 material management or governance events in the past 24 months, led by legal/regulatory items. Historically, Information Technology names rated neutral grew net income 64% of the time over the next year (vs 57% for the rest of the cohort, n=1040).
Not investment advice. As of 2026-06-12.
via XLK
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-12.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
IBM aims to achieve more than 5% constant currency revenue growth for the fiscal year.
IBM plans to increase its full-year free cash flow by about $1 billion year-over-year.
IBM plans to invest more than $10 billion in quantum technologies over the next five years.
Why it matters: This would indicate IBM is struggling to meet its growth target for the year.
Confirms:Q2 revenue growth reported below 5% at constant currency.
Disproves:Q2 revenue growth reported above 5% at constant currency.
Why it matters: Achieving this target shows IBM's ability to generate cash and invest in growth.
Confirms:Free cash flow reported at $1 billion or more year-over-year increase.
Disproves:Free cash flow growth reported below $1 billion year-over-year.
Results of Operations and Financial Condition. The registrant’s press release dated April 22, 2026, regarding its financial results for the period ended March 31, 2026, including consolidated financial statements for the period ended March 31, 2026, is Exhibit 99.1 of this Form 8-K. In an effort to provide investors with additional information regarding the company’s results as determined by generally accepted accounting principles (GAAP), the company has disclosed in the attached press relea…